These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29991543)

  • 1. Empirical treatment of tuberculosis: TB or not TB?
    Webb E; Kali Vanan N; Biswas R
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 29991543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis in children with tuberculosis: a case report and review of the literature.
    Sanchez-Codez M; Hunt WG; Watson J; Mejias A
    BMC Pulm Med; 2020 Jun; 20(1):173. PubMed ID: 32546255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study.
    Song JH; Yoon SY; Park TY; Heo EY; Kim DK; Chung HS; Lee JK
    Respir Res; 2019 Dec; 20(1):283. PubMed ID: 31842883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Hepatotoxicity From Antituberculosis Therapy: A Five-Year Experience From South India.
    Saha A; Shanthi F X M; Winston A B; Das S; Kumar A; Michael JS; Balamugesh T
    J Prim Care Community Health; 2016 Jul; 7(3):171-4. PubMed ID: 27056794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment.
    Chen L; Bao D; Gu L; Gu Y; Zhou L; Gao Z; Huang Y
    BMC Infect Dis; 2018 Jul; 18(1):295. PubMed ID: 29970037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of renal function-based anti-tuberculosis drug dosage adjustment on efficacy and safety outcomes in pulmonary tuberculosis complicated with chronic kidney disease.
    Saito N; Yoshii Y; Kaneko Y; Nakashima A; Horikiri T; Saito Z; Watanabe S; Kinoshita A; Saito K; Kuwano K
    BMC Infect Dis; 2019 May; 19(1):374. PubMed ID: 31046706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of diagnostic and treatment practices of pulmonary tuberculosis management amongst health practitioners in Haryana, north India.
    Singh AK; Salve H; Selvaraj K; Rai SK; Kant S
    Rural Remote Health; 2014; 14(4):2784. PubMed ID: 25416920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When students become patients: TB disease among medical undergraduates in Cape Town, South Africa.
    Van der Westhuizen HM; Dramowski A
    S Afr Med J; 2017 May; 107(6):475-479. PubMed ID: 28604316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tuberculous drug induced liver injury - Do we need to rethink?
    Pandey J; Madaan P; Saini L; Verma S
    Indian J Tuberc; 2020 Apr; 67(2):260-261. PubMed ID: 32553322
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatic jaundice in patients with pulmonary tuberculosis treated with various combinations of antitubercular drugs].
    Kubiak Z
    Gruzlica; 1968 Oct; 36(11):1133-5. PubMed ID: 5710701
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis.
    Musso M; Mosti S; Gualano G; Mencarini P; Urso R; Ghirga P; Rianda A; Del Nonno F; Goletti D; Palmieri F
    BMC Infect Dis; 2019 Oct; 19(1):882. PubMed ID: 31640579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrasonic examination of the liver in patients with pulmonary tuberculosis].
    Ivanov AK; Dzodzuashvili KA
    Klin Med (Mosk); 1990 Jan; 68(1):100-3. PubMed ID: 2186199
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver function testing in African patients on treatment for tuberculosis.
    Davies PD
    East Afr Med J; 1985 Jul; 62(7):486-90. PubMed ID: 4076028
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases.
    Baghaei P; Tabarsi P; Chitsaz E; Saleh M; Marjani M; Shemirani S; Pooramiri MV; Kazempour M; Farnia P; Fahimi F; Mansouri D; Masjedi M
    Am J Ther; 2010; 17(1):17-22. PubMed ID: 19535968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis due to anti-tuberculous drugs.
    Aggarwal NP
    Indian J Chest Dis Allied Sci; 1992; 34(4):231-2. PubMed ID: 1302758
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India.
    Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN
    J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patients.
    Tostmann A; van den Boogaard J; Semvua H; Kisonga R; Kibiki GS; Aarnoutse RE; Boeree MJ
    Trop Med Int Health; 2010 Feb; 15(2):268-72. PubMed ID: 20409289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent Drug-Induced Hepatitis in Tuberculosis-Comparison of Two Drug Regimens.
    Shamaei M; Mirsaeidi M; Baghaei P; Mosaei H; Marjani M; Tabarsi P
    Am J Ther; 2017; 24(2):e144-e149. PubMed ID: 26057141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrazinamide-induced granulomatous hepatitis.
    Knobel B; Buyanowsky G; Dan M; Zaidel L
    J Clin Gastroenterol; 1997 Jun; 24(4):264-6. PubMed ID: 9252856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.